Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin

Clin Microbiol Infect. 2021 Apr;27(4):637-638. doi: 10.1016/j.cmi.2020.09.007. Epub 2020 Sep 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antithrombins
  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Coronavirus*
  • Disease Outbreaks
  • Humans
  • Immunization, Passive
  • Plasma
  • SARS-CoV-2

Substances

  • Antithrombins